However, the mRNA and nuclear activities of NF-κB, as well as the hepatic levels of IL-6 and TNF-α, were significantly higher in the T2DM + SFFE + brusatol-treated rats, as compared with T2DM + SFFE-treated rats (Figure 4A–D). This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.